|
MAPK1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.050000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.617700E-04 |
| Normal-vs-Stage2 |
3.324600E-01 |
| Normal-vs-Stage3 |
8.660400E-01 |
| Normal-vs-Stage4 |
4.670800E-01 |
| Stage1-vs-Stage2 |
2.374400E-01 |
| Stage1-vs-Stage3 |
6.199200E-03 |
| Stage1-vs-Stage4 |
1.036020E-03 |
| Stage2-vs-Stage3 |
4.388000E-01 |
| Stage2-vs-Stage4 |
1.707390E-01 |
| Stage3-vs-Stage4 |
4.484200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.356800E-03 |
| Normal-vs-AfricanAmerican |
1.325750E-02 |
| Normal-vs-Asian |
4.583200E-01 |
| Caucasian-vs-AfricanAmerican |
3.8165000000312E-06 |
| Caucasian-vs-Asian |
3.138000E-01 |
| AfricanAmerican-vs-Asian |
6.302200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.385000E-01 |
| Normal-vs-Female |
1.184220E-03 |
| Male-vs-Female |
7.079000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.675800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.107790E-02 |
| Normal-vs-Age(61-80Yrs) |
1.089210E-01 |
| Normal-vs-Age(81-100Yrs) |
6.976800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.444400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.060760E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.620000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.987800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.591200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.497600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.610070E-02 |
| Normal-vs-Grade 2 |
3.840500E-04 |
| Normal-vs-Grade 3 |
1.671390E-01 |
| Normal-vs-Grade 4 |
8.544000E-03 |
| Grade 1-vs-Grade 2 |
2.250600E-01 |
| Grade 1-vs-Grade 3 |
4.756000E-02 |
| Grade 1-vs-Grade 4 |
7.82980000000322E-05 |
| Grade 2-vs-Grade 3 |
4.005600E-02 |
| Grade 2-vs-Grade 4 |
7.40879999572286E-08 |
| Grade 3-vs-Grade 4 |
3.183700E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.97315513822605E-12 |
| Normal-vs-ccB subtype |
1.196180E-01 |
| ccA subtype-vs-ccB subtype |
1.55431223447522E-15 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.002400E-02 |
| Normal-vs-N1 |
8.500800E-01 |
| N0-vs-N1 |
5.028600E-01 |
|
|
